• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Vericel Corp (VCEL)

Common Shares
Sell: $33.66|Buy: $42.70|Change: 0.72 (-1.96%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Address

64 Sidney Street
Cambridge
MA
USA
02139

Telephone

+1 800 556-0311

Website

https://www.vcel.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Vericel Corp Third Quarter Earnings Conference Call for 20262026-11-06T08:30:00
Vericel Corp Third Quarter Earnings Results for 20262026-11-06T00:00:00
Vericel Corp Second Quarter Earnings Conference Call for 20262026-07-31T08:30:00
Vericel Corp Second Quarter Earnings Results for 20262026-07-31T00:00:00
Vericel Corp First Quarter Earnings Conference Call for 20262026-05-08T08:30:00
Vericel Corp First Quarter Earnings Results for 20262026-05-08T00:00:00
Vericel Corp Annual General Meeting for 20262026-04-30T09:00:00
Vericel Corp Fourth Quarter Earnings Conference Call for 20252026-02-27T08:30:00
Vericel Corp Fourth Quarter Earnings Results for 20252026-02-27T00:00:00
Vericel Corp Annual Report for 20252026-02-27T00:00:00

Previous key dates

NameKey Date
Stephens Annual Investment Conference2025-11-20T11:00:00
Vericel Corp Third Quarter Earnings Conference Call for 20252025-11-06T08:30:00
Vericel Corp Third Quarter Earnings Result for 20252025-11-06T00:00:00
Wells Fargo Healthcare Conference2025-09-04T15:45:00
Vericel Corp Second Quarter Earnings Conference Call for 20252025-07-31T08:30:00
Vericel Corp Second Quarter Earnings Results for 20252025-07-31T00:00:00
Truist Securities MedTech Conference2025-06-17T09:20:00
Bank of America Securities 2025 Healthcare Conference2025-05-14T12:20:00
Vericel Corp First Quarter Earnings Conference Call for 20252025-05-08T08:30:00
Vericel Corp First Quarter Earnings Results for 20252025-05-08T00:00:00
Vericel Corp Annual General Meeting for 20252025-04-30T09:00:00
Leerink Partners 2025 Global Healthcare Conference2025-03-12T10:00:00
Canaccord Genuity 2025 Musculoskeletal Conference2025-03-10T11:30:00
TD Cowen 45th Annual Health Care Conference2025-03-05T09:50:00
Vericel Corp Fourth Quarter Earnings Conference Call for 20242025-02-27T08:30:00
Vericel Corp Fourth Quarter Earnings Result for 20242025-02-27T00:00:00
Vericel Corp Annual Report for 20242025-02-27T00:00:00
43rd Annual J.P. Morgan Healthcare Conference2025-01-15T10:30:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.